错误:一种针对KRASG12V的双特异性T细胞参与者促进了对结直肠固体瘤的免疫力
Molecular therapy. Oncology
|March 9, 2026
概括
这项研究纠正了先前发表的一篇文章DOI. 校正确保准确的引用和参考,用于该领域的未来研究.
科学领域:
- 科学出版业的科学出版.
- 学术传播学术交流
背景情况:
- 确保发表的科学文献的准确性对于研究的完整性至关重要.
- 正确的引用和引用是学术交流的基本方面.
研究的目的:
- 为特定的物品提供纠正DOI.
- 保持科学记录的准确性和可靠性.
主要方法:
- 已经发布了纠正通知.
- 文章的DOI已经更新,以确保正确的识别.
主要成果:
- 校正确保可以准确地定位和引用文章.
- 这维护了科学文献的完整性.
结论:
- 准确的DOI对于科学出版物的可追溯性至关重要.
- 校正是保持科学话语质量的重要机制.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K